AstraZeneca is collecting its COVID-19 vaccines.
AstraZeneca says it is collecting these shipments from around the world due to surplus COVID-19 vaccines.
The company has announced that since the start of the COVID-19 pandemic, several updated versions of vaccines made by various companies to combat the coronavirus have entered the market, leading to surplus vaccines for the disease.
Earlier, following a class action lawsuit in Britain, the company admitted that rare cases of AstraZeneca’s COVID-19 vaccines had led to blood clots and patient deaths.
Persian
مشاهده این مقاله به زبان فارسی